Embedded within a larger randomized controlled trial assessing implementation strategies for delivering medications for opioid use disorder (MOUD) in jails and during transition to community treatment, this article focuses on barriers to MOUD. Twenty-three qualitative interviews representing 19 organizations were conducted to understand these barriers. The three that surfaced as most pertinent are: policy, organizational structure, and stigma related to addiction and incarceration. This study also found a double stigma for those incarcerated and struggling with addiction, amplifying barriers to MOUD. Improving MOUD implementation is essential to reducing fatal overdoses, enhancing care postrelease, and expanding treatment access in the community.
AdamsZ.TaylorB. G.FlanaganE.KwonE.Johnson-KwochkaA. V.ElkingtonK. S.AalsmaM. C. (2021). Opioid use disorder stigma, discrimination, and policy attitudes in a U.S. National sample of young adults. Journal of Adolescent Health, 69(2), 321–328. https://doi.org/10.1016/j.jadohealth.2020.12.142
2.
AhaltC.WilliamsB. (2017). Advancing evidence-based interventions at the intersection of criminal justice and health. International Journal of Prisoner Health, 13(3/4), 137–138. https://doi.org/10.1108/IJPH-05-2017-0023
BelenkoS.HillerM.HamiltonL. (2013). Treating substance use disorders in the criminal justice system. Current Psychiatry Reports, 15(11), 414. https://doi.org/10.1007/s11920-013-0414-z
5.
BrenoA.CarterT.VechinskiJ.MolfenterT.ClarkK.TaxmanF. S. (2023). Better together: Exploring staff perceptions of MOUD treatment across agencies. Journal of Substance Abuse Treatment, 128, Article 108370. https://doi.org/10.1016/j.jsat.2021.108370
6.
BrezelE. R.PowellT.FoxA. D. (2020). An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated. Substance Abuse, 41(2), 150–154. https://doi.org/10.1080/08897077.2019.1695706
7.
BurnetteJ. L.HoytC. L.BeckerW.O'KeefeP. A. (2025). Addiction stigma: Potential costs and benefits of beliefs about the nature of addiction. Stigma and Health, 10(2), 164–175. https://doi.org/10.1037/sah0000593
ChicoineG.CôtéJ.PepinJ.FontaineG.Maheu-CadotteM.HongQ.RouleauG.ZieglerD.Jutras-AswadD. (2021). Effectiveness and experiences of the extension for community healthcare outcomes (ECHO) model in developing competencies among healthcare professionals: A mixed methods systematic review protocol. Systematic Reviews, 10, 313. https://doi.org/10.1186/s13643-021-01832-0
11.
Dickson-GomezJ.SpectorA.WeeksM.GalletlyC.McDonaldM.Green MontaqueH. D. (2022). You're not supposed to be on it forever: Medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Substance Abuse: Research and Treatment, 16, 11782218221103859. https://doi.org/10.1177/11782218221103859
12.
DurstJ. (2022). Barring methadone behind bars: How prisons err when denying methadone treatment to inmates with opioid use disorder. Mitchell Hamline Law Review, 48(1), Article 6.
13.
EvansE. A.WilsonD.FriedmannP. D. (2022). Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Dependency, 231, Article 109254. https://doi.org/10.1016/j.drugalcdep.2021.109254
14.
FairleyM.HumphreysK.JoyceV. R.BounthavongM.TraftonJ.CombsA.OwensD. K. (2021). Cost-effectiveness of treatments for opioid use disorder. JAMA Psychiatry, 78(7), 767–777. https://doi.org/10.1001/jamapsychiatry.2021.0247
15.
FeingoldZ. R. (2021). The stigma of incarceration experience: A systematic review. Psychology Public Policy and Law, 27(4), 550–569. https://doi.org/10.1037/law0000319
16.
FengR. Y.KrygsmanA.VaillancourtT.VitoroulisI. (2023). Experiences of racial microaggression among immigrant and Canadian-born young adults: Effects of double stigma on mental health and service use. The International Journal of Social Psychiatry, 69(7), 1723–1735. https://doi.org/10.1177/00207640231174374
17.
Flanagan BalawajderE.DucharmeL.TaylorB. G.LamudaP.KolakM.FriedmannP.PollackH.SchneiderJ. (2024). Factors associated with the availability of medications for opioid use disorder in US jails. JAMA Network Open, 7(9), Article e2434704. https//doi.org10.1001/jamanetworkopen.2024.34704
18.
GoffmanE. (1963). Stigma: Notes on the management of spoiled identity. Prentice-Hall.
19.
GreenT. C.ClarkeJ.Brinkley-RubinsteinL.MarshallB.Alexander-ScottN.BossR.RichJ. (2018). Post incarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry, 75(4), 405–407. https://doi.org/10.1001/jamapsychiatry.2017.4614
20.
GrellaC. E.OstileE.ScottC. K.DennisM.CarnavaleJ. (2020). A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. International Journal of Drug Policy, 81, Article 102768. https//doi.org10.1016/j.drugpo.2020.102768
21.
HenningerA.Hung-EnS. (2014). History of substance abuse treatment. In BruinsmaG. J. N.WeisburdD. L. (Eds.), Encyclopedia of criminology and criminal justice (pp. 2257–2269). Springer. https://doi.org/10.1007/978-1-4614-5690-2_544
22.
HowellB. A.EarnshawV. A.GarciaM.TaylorA.MartinK.FoxA. D. (2022). The stigma of criminal legal involvement and health: A conceptual framework. Journal of Urban Health, 99(1), 92–101.
23.
HsiehH. F.ShannonS. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288. https://doi.org/10.1177/1049732305276687
24.
KnightD. K.BecanJ. E.FlynnP. M. (2012). Organizational consequences of staff turnover in outpatient substance abuse treatment programs. Journal of Substance Abuse Treatment, 42(2), 143–150. https://doi.org/10.1016/j.jsat.2011.10.005
25.
KrawczykN.BandaraS.MerrittS.ShahH.DuncanA.McEnteeB.SchiffM.AhmadN. J.WhaleyS.LatimoreA.SalonerB. (2022). Jail-based treatment for opioid use disorder in the era of bail reform: A qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. Addiction Science Clinical Practice, 17(1), 30. https://doi.org/10.1186/s13722-022-00313-6
26.
MaddenE. F.FrabisF.CohnJ.QeadanF.MannC. R.GreenwaldM. K. (2024). Perceptions of structural and provider-based substance use stigma interventions among primary care professionals. Drug and Alcohol Dependence Reports, 12, Article 100259. https://doi.org/10.1016/j.dadr.2024.100259
27.
MaruschakL. M.MintonT. D.ZengZ. (2023). Opioid use disorder screening and treatment in local jails, 2019. U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics.
28.
McNeelyH. L.SchreiberT. L.SwannW. L.AmuraC. (2024). Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: A qualitative analysis. Health & Justice, 12, 26. https://doi.org/10.1186/s40352-024-00280-x
29.
MolfenterT.KimH.KimJ. S.KisickiA.KnudsenH. K.HorstJ.BrownR.MaddenL. M.ToyA.HaramE.JacobsonN. (2023). Enhancing use of medications for opioid use disorder through external coaching. Psychiatric Services, 74(3), 265–271. https://doi.org/10.1176/appi.ps.202100675
30.
MolfenterT.VechinskiJ.KimJ. S.ZhangJ.MengL.TveitJ.TaxmanF. S. (2025). Assessing the comparative effectiveness of ECHO and coaching implementation strategies in a jail/provider MOUD implementation trial. Implementation Science, 20(1), 1–12. https://doi.org/10.1186/s13012-025-01419-6
31.
MolfenterT.VechinskiJ.TaxmanF. S.BrenoA. J.ShawC. C.PerezH. A. (2021). Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use. Journal for Substance Abuse Treatment, 128, Article 108370. https://doi.org/10.1016/j.jsat.2021.108370
32.
MooreK. E.JohnsonJ. E.LuomaJ. B.TaxmanF.PackR.CorriganP.HartJ.SloneJ. D. (2023). A multi-level intervention to reduce the stigma of substance use and criminal involvement: A pilot feasibility trial protocol. Health & Justice, 11(1), 24. https://doi.org/10.1186/s40352-023-00224-x
PaulN.KennedyA. J.TaubenbergerS.ChangJ. C.HackerK. (2022). Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates. Substance Abuse, 43(1), 742–748. https://doi.org/10.1080/08897077.2021.2007518
36.
PfaffA.CochranA.VechinskiJ.MolfenterT.Zayas-CabánG. (2023). The association between attitudes and the provision of medications for opioid use disorder (MOUD) in United States jails. Drug and Alcohol Dependence Reports, 10, Article 100211. https://doi.org/10.1016/j.dadr.2023.100211
37.
PivovarovaE.EvansE. A.StopkaT. J.SantelicesC.FergusonW. J.FriedmannP. D. (2022). Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug and Alcohol Dependence, 234, Article 109394. https://doi.org/10.1016/j.drugalcdep.2022.109394
38.
PourtaherE.GelbergK. H.FallicoM.EllendonN.LiS. (2024). Expanding access to medication for opioid use disorder (MOUD) in jails: A comprehensive program evaluation. Journal of Substance Use and Addiction Treatment, 161, Article 209248. https://doi.org/10.1016/j.josat.2023.209248
39.
StopkaT. J.RottapelR. E.FergusonW. J.PivovarovaE.Toro-MejiasL. D.FriedmannP. D.EvansE. A. (2022). Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. The International Journal on Drug Policy, 110, Article 103803. https://doi.org/10.1016/j.drugpo.2022.103803
40.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). Use of medication-assisted treatment for opioid use disorder in criminal justice settings. (HHS Publication No. PEP19-MATUSECJS). National Mental Health and Substance Use Policy Laboratory.
41.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2021). Medications for opioid use disorder (Treatment Improvement Protocol [TIP] Series 63, Publication No. PEP21-02-01-002). U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration.
YuY.MatlinS. L.CrustoC. A.HunterB.TebesJ. K. (2022). Double stigma and help-seeking barriers among blacks with a behavioral health disorder. Psychiatric Rehabilitation Journal, 45(2), 183–191. https://doi.org/10.1037/prj0000507
44.
ZhaoX.HororszkoU. A.SmithL. R.MurphyA.TaxmanF. S. (2024). Using narrative and informational messages to improve correctional professionals’ attitude toward medications for opioid use disorder [Poster Presentation]. NIDA JCOIN Coordination and Translation Center, Bethesda, MD.
